XOMA Corporation (XOMA): Price and Financial Metrics

XOMA POWR Grades

• Quality is the dimension where XOMA ranks best; there it ranks ahead of 86% of US stocks.
• XOMA's strongest trending metric is Growth; it's been moving up over the last 179 days.
• XOMA's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

XOMA Stock Summary

• XOMA's went public 33.01 years ago, making it older than 88.85% of listed US stocks we're tracking.
• The ratio of debt to operating expenses for XOMA Corp is higher than it is for about merely 5.84% of US stocks.
• With a year-over-year growth in debt of -98.92%, XOMA Corp's debt growth rate surpasses only 1.63% of about US stocks.
• Stocks that are quantitatively similar to XOMA, based on their financial statements, market capitalization, and price volatility, are PLBY, BEEM, CHCI, MYTE, and ASM.
• XOMA's SEC filings can be seen here. And to visit XOMA Corp's official web site, go to www.xoma.com.

XOMA Valuation Summary

• XOMA's price/sales ratio is 12; this is 215.79% higher than that of the median Healthcare stock.
• Over the past 243 months, XOMA's price/sales ratio has gone down 69.
• XOMA's price/sales ratio has moved down 69 over the prior 243 months.

Below are key valuation metrics over time for XOMA.

XOMA Growth Metrics

Its year over year net cashflow from operations growth rate is now at 300.24%.
• Its 2 year net income to common stockholders growth rate is now at -189.7%.
• The 3 year revenue growth rate now stands at -77.15%.

XOMA's revenue has moved up $35,933,000 over the prior 15 months.

The table below shows XOMA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	38.16	22.678	7.787
2021-09-30	29.797	9.714	5.429
2021-06-30	29.414	10.353	10.156
2021-03-31	28.957	11.458	10.153
2020-12-31	29.385	10.092	13.298
2020-09-30	2.227	-11.734	-12.712

XOMA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XOMA has a Quality Grade of C, ranking ahead of 66.13% of graded US stocks.
• XOMA's asset turnover comes in at 0.233 -- ranking 184th of 682 Pharmaceutical Products stocks.
• DARE, WINT, and TCON are the stocks whose asset turnover ratios are most correlated with XOMA.

The table below shows XOMA's key quality metrics over time.